Herman W T Van Vlijmen

Title: Innovations and Contributions of Herman W T Van Vlijmen

Introduction

Herman W T Van Vlijmen is a notable inventor based in Mechelen, Netherlands. He has made significant contributions in the fields of cell biology, immunology, and oncology. With a total of 2 patents to his name, his work focuses on the development of humanized antibodies that have the potential to impact medical treatments.

Latest Patents

Herman's latest patents involve the creation of humanized antibodies that recognize αβ integrins. These antibodies comprise a variable region of nonhuman origin and at least a portion of an immunoglobulin of human origin. The inventions provide methods for the preparation of such antibodies, pharmaceutical compositions that include them, and methods for treating, diagnosing, and preventing various diseases and disorders. Additionally, his patents relate to the identification of differential expression of the integrin αβ on the surfaces of tumor cells and tissues. This differential expression can be used to determine the metastatic potential of tumor cells, leading to methods for diagnosis and treatment of tumor metastasis.

Career Highlights

Herman W T Van Vlijmen is associated with Biogen Idec Ma Inc., where he continues to innovate and contribute to advancements in medical science. His work is pivotal in the ongoing research and development of therapies that target cancer and other serious diseases.

Collaborations

Herman has collaborated with notable coworkers such as Shelia Marie Violette and Louise A Koopman. These partnerships enhance the research and development efforts within his field.

Conclusion

Herman W T Van Vlijmen's contributions to the fields of cell biology, immunology, and oncology through his patents and collaborations highlight his role as an influential inventor. His work continues to pave the way for advancements in medical treatments and therapies.